Savara

Avalyn Pharma

The company develops inhaled medicines to treat patients with rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases.

Respira

This biopharmaceutical company develops inhaled drug-device therapies for patients with cardiopulmonary diseases such as pulmonary hypertension and interstitial lung disease.

Gossamer Bio

This biopharmaceutical company develops inhaled therapies for patients suffering from pulmonary arterial hypertension and interstitial lung disease.

Breath Therapeutics

This biopharmaceutical company develops inhaled drug-aerosol therapies for patients with bronchiolitis obliterans syndrome and other severe respiratory diseases.

Kither Biotech

This company develops inhaled therapies for patients with respiratory diseases such as chronic obstructive pulmonary disease and cystic fibrosis.

Liquidia Technologies

This biopharmaceutical company develops inhaled therapies for patients with pulmonary arterial hypertension and other cardiopulmonary diseases using a proprietary particle engineering platform.

Aer Therapeutics

This biopharmaceutical company develops inhaled mucolytic treatments for patients with muco-obstructive lung diseases, including chronic obstructive pulmonary disease and asthma.

aTyr Pharma

The company develops protein-based immunomodulatory medicines for patients suffering from inflammatory lung diseases, such as pulmonary sarcoidosis, and various types of cancer.